Skip to main content

Clinical trial results push St. Louis cancer screening startup toward commercialization

St. Louis life sciences startup Geneoscopy is taking steps toward commercializing its at-home, preventive screening test for colorectal cancer after a clinical trial yielded strong results.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.